{
  "disease_name": "Glioblastoma",
  "synonyms": [
    "Glioblastoma multiforme",
    "GBM"
  ],
  "summary": "Glioblastoma is the most aggressive and common type of primary brain cancer, originating from astrocytes. It is characterized by rapid growth, infiltration, and a poor prognosis. Diagnosis is typically made through imaging (CT, MRI) and biopsy, with molecular characterization becoming increasingly important.",
  "causes": [
    "Unknown for most cases",
    "Genetic disorders (e.g., neurofibromatosis, Li-Fraumeni syndrome)",
    "Previous radiation therapy",
    "Infection with oncogenic cytomegalovirus (CMV)"
  ],
  "risk_factors": [
    "Exposure to ionizing radiation (including CT scan radiation)",
    "Hereditary syndromes (e.g., neurofibromatosis, Li-Fraumeni syndrome, tuberous sclerosis, Turcot syndrome)",
    "Smoking",
    "Exposure to pesticides",
    "Working in petroleum refining or rubber manufacturing",
    "Male sex",
    "Increasing age (average age at diagnosis is 64)"
  ],
  "symptoms": [
    "Headaches",
    "Personality changes",
    "Nausea",
    "Symptoms similar to stroke",
    "Seizures",
    "Vomiting",
    "Memory loss",
    "Changes in mood or concentration",
    "Localized neurological problems",
    "Unconsciousness (in later stages)"
  ],
  "diagnosis": [
    "CT scan",
    "MRI scan",
    "Tissue biopsy",
    "Perfusion MRI (for tumor blood flow)",
    "MR spectroscopy (for metabolite concentration)",
    "Genetic and chromosomal testing (e.g., IDH1/IDH2 mutation status, EGFR amplification, TERT promoter mutation, ATRX expression)"
  ],
  "treatments": [
    "Surgery (surgical removal/decompression)",
    "Radiation therapy",
    "Chemotherapy (e.g., temozolomide)",
    "Corticosteroids (e.g., dexamethasone) for symptom management",
    "Anticonvulsants for seizure management",
    "Alternating electric field therapy",
    "Gene therapy (experimental)",
    "Oncolytic virotherapy (experimental)",
    "Intranasal drug delivery (experimental)",
    "Nanoparticle-based therapeutics (experimental)",
    "Supportive care",
    "Physical rehabilitation and exercise"
  ],
  "related_genes": [
    "EGFR (epidermal growth factor receptor)",
    "TP53 (p53)",
    "PDGFRA (platelet-derived growth factor receptor alpha)",
    "NF1 (neurofibromin 1)",
    "MGMT (O6-methylguanine-DNA methyltransferase)",
    "IDH1 (isocitrate dehydrogenase 1)",
    "IDH2 (isocitrate dehydrogenase 2)",
    "RB (retinoblastoma)",
    "PI3K/AKT/mTOR pathway genes",
    "STAT3",
    "CYP1B1-AS1",
    "AC003092.1",
    "TMZR1-eRNA"
  ],
  "subtypes": [
    "Classical",
    "Proneural",
    "Mesenchymal",
    "IDH-wild type glioblastoma (current WHO classification)",
    "Astrocytoma, IDH mutant, grade 4 (formerly secondary glioblastoma)"
  ]
}